Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia (Q36579938)
Jump to navigation
Jump to search
scientific article published on 12 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia |
scientific article published on 12 June 2015 |
Statements
1 reference
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia (English)
1 reference
David Walling
1 reference
Stephen R Marder
1 reference
John Kane
1 reference
W Wolfgang Fleischhacker
1 reference
Richard S E Keefe
1 reference
David A Hosford
1 reference
Chris Dvergsten
1 reference
Anthony C Segreti
1 reference
Jessica S Beaver
1 reference
Steven M Toler
1 reference
John E Jett
1 reference
Geoffrey C Dunbar
1 reference
12 June 2015
1 reference
1 reference
335-343
1 reference
Identifiers
1 reference
1 reference
1 reference